GenMark Diagnostics to Participate in the Cowen Health Care Conference

CARLSBAD, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen Health Care Conference in Boston, Massachusetts.

GenMark’s management is scheduled to present on Tuesday, March 3, 2020 at 10:40am ET. Interested parties can access a live and archived webcast of the presentation at ir.genmarkdx.com.

About GenMark Diagnostics GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

Investor Relations ContactLeigh Salvo(415) 937-5404[email protected]

You May Also Be Interested In

• Cerrado Gold Announces Second Quarter 2026 Financial Results
• Lion Copper Announces Director Transition and Appointment of Co-Chairman
• Atico Reports Consolidated Financial Results for the Second Quarter of 2026